|
1. BIOLOGIE
|
|
|
|
|
1.4 BIOLOGIE - TECHNOS, MODÈLES
|
|
|
|
2.11 ETIOLOGIE - ALIMENTATION
|
|
|
|
3.1.1 PRÉVENTION - TABAC - E-CIGS
|
|
|
|
|
4.12 BIOPSIES LIQUIDES
|
|
|
|
5.1 TRAITEMENTS - PRÉ-CLINIQUE
|
|
|
|
|
5.10 TRAITEMENTS - ESSAIS
|
|
|
|
|
5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE
|
|
|
|
5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES
|
|
|
|
5.12.3 IMMUNOTHÉRAPIES-COMBINAISONS
|
|
|
|
|
5.2.3 PHARMA - ÉCONOMIE
|
|
|
|
Is it time to nationalise the pharmaceutical industry? [BMJ]
|
|
|
|
|
|
Drug companies fail to take account of the public interest and relentlessly focus on short term returns, say Mariana Mazzucato and Henry Lishi Li. But Ara Darzi argues that the profits drug companies make are vital for developing new medicines.
|
|
|
|
|
|
|
6.5 MÉDECINES ALTERNATIVES/COMPLÉMENTAIRES
|
|
|